Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: Mature results of a phase II trial

Strahlentherapie und Onkologie

Volumn 184, Issue 9, 2008, Pages 450-456

  Dunst, Juergen ^a,k   Debus, Juergen ^b   Rudat, Volker ^c   Wulf, Joern ^d   Budach, Wilfried ^e   Hoelscher, Tobias ^f   Reese, Thomas ^g   Mose, Stephan ^h   Roedel, Claus ^h   Zuehlke, Helmut ⁱ   Hinke, Axel ^j  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF HAMBURG   (Germany)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e UNIVERSITY OF TÜBINGEN   (Germany)

^f DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^g MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^h GOETHE UNIVERSITY   (Germany)

ⁱ Paul Gerhard Hospital   (Germany)

^j WiSP GmbH   (Germany)

^k UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

more..

Author keywords

Capecitabine; Neoadjuvant therapy; Phase II study; Radiotherapy; Rectal cancer

Indexed keywords

CAPECITABINE; FLUOROURACIL; FOLINIC ACID;

ACUTE TOXICITY; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; ERYTHEMA; FEMALE; FOLLOW UP; GERMANY; HAND FOOT SYNDROME; HUMAN; LEUKOPENIA; LYMPH NODE; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; RADIATION DOSE; RECTUM CANCER; TREATMENT RESPONSE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; LEUCOVORIN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROCTOCOLECTOMY, RESTORATIVE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RECTAL NEOPLASMS; RECTUM;

EID: 56549126162     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-008-1751-4     Document Type: Article

References (39)

1. Bajetta E, Beretta E, Di Bartolomeo M, et al. Capecitabine chemoradiation for rectal cancer after curative surgery. J Chemother 2006;18:85-9.
2. Cassidy J, Twelves C, Van Cutsem E, et al. First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin. Ann Oncol 2002;13:566-75.
3. Chau I, Brown G, Cunningham D, et al. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor risk rectal cancer. J Clin Oncol 2006;24:668-74.
4. Craven I, Crellin A, Cooper R, et al. Preoperative radiotherapy combined with 5 days per week capecitabine chemotherapy in locally advanced rectal cancer. Br J Cancer 2007;97:1333-7.
5. Das P, Lin EH, Bhatia S, et al. Preoperative chemoradiation with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysis. Int J Radiat Oncol Biol Phys 2006;66:1378-83.
6. De Paoli A, Chiara S, Luppi G, et al. Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable rectal cancer: a multicentric phase II study. Ann Oncol 2006;17:246-51.
7. Desai SP, El-Rayes BF, Ben-Josef E, et al. A phase II study of preoperative capecitabine and radiation therapy in patients with rectal cancer. Am J Clin Oncol 2007;30:340-5.
8. Dunst J, Reese T, Sutter T, et al. Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer. J Clin Oncol 2002;20:3983-91.
9. Dupuis O, Vié B, Liedo G, et al. Preoperative treatment combining capecitabine with radiation therapy in rectal cancer: a GERCOR phase II study. Oncology 2007;73:169-76.
10. Fleming TR. One-sample multiple testing procedure for phase II clinical trials. Biometrics 1982;38:143-51.
11. Freedman GM, Meropol NJ, Sigurdson ER, et al. Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2007;67:1389-93.
12. Gagel B, Piroth M, Pinkawa M, et al. Gemcitabine concurrent with thoracic radiotherapy after induction chemotherapy with gemcitabine/vinorelbine in locally advanced non-small cell lung cancer. A phase I study. Strahlenther Onkol 2006;182:263-9.
13. Gerard JP, Conroy O, Bonnetain T, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 2006;24:4620-5.
14. Glynne-Jones R, Dunst J, Sebag-Montefiore D. The integration of oral capecitabine into chemoradiation regimens for locally advanced rectal cancer: how successful have we been? Ann Oncol 2006;17:361-71.
15. Glynne-Jones R, Sebag-Montefiore D, Maughan TS, et al. A phase I dose escalation study of oral capecitabine in combination with oxaliplatin and pelvic radiotherapy (XELOX-RT) in patients with locally advanced rectal cancer. Ann Oncol 2006;17:50-6.
16. Kim JS, Kim JS, Cho MJ, et al. Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2002;54:403-8.
17. Klautke G, Fietkau R. Intensified neoadjuvant radiochemotherapy of locally advanced rectal cancer: a review. Int J Colorectal Dis 2007;22: 457-65.
18. Klautke G, Kuechenmeister U, Foitzik T, et al. Intensified irinotecan-based neoadjuvant chemoradiation in rectal cancer: four consecutive designed studies to minimize acute toxicity and to optimise efficacy measured by pathologic complete response. Radiother Oncol 2007;85:379-84.
19. Kocakova I, Svoboda M, Klocova K, et al. Combined therapy of locally advanced rectal adenocarcinoma with capecitabine and concurrent radiotherapy. Proc Am Soc Clin Oncol 2004;23:299.abstract 3720.
20. Korkolis DP, Boskos CS, Plataniotis GD, et al. Pre-operative chemoradiotherapy with oral capecitabine in locally advanced, resectable rectal cancer. Anticancer Res 2007;27:541-5.
21. Kortmann B, Reimer T, Gerber B, et al. Concurrent radiochemotherapy of locally recurrent or advanced sarcomas of the uterus. Strahlenther Onkol 2006;182:318-24.
22. Lay GC, Caraul B, Dessi M, et al. Phase II study of preoperative irradiation and chemotherapy with capecitabine in patients with locally advanced rectal carcinoma. J Exp Clin Cancer Res 2007;26:61-70.
23. Lin EH, Skibber J, Delcos M, et al. A phase II study of capecitabine and concomitant boost radiotherapy (XRT) in patients with locally advanced rectal cancer. J Clin Oncol 2005;23:Suppl 16:269s.abstract 3593.
24. Ngan SY, Michael M, Mackay J, et al. A phase I trial of preoperative radiotherapy and capecitabine for locally advanced, potentially resectable rectal cancer. Br J Cancer 2004;91:1019-24.
25. Rades D, Schulte R, Yekebas EF, et al. Radio(chemo)therapy plus resection versus radio(chemo)therapy alone for the treatment of stage III esophageal cancer. Strahlenther Onkol 2007;183:10-6.
26. Rhomberg W, Hammer J, Sedlmayer F, et al. Irradiation with and without razoxane in the treatment of incompletely resected or inoperable recurrent rectal cancer. Results of a small randomized multicenter study. Strahlenther Onkol 2007;183:380-4.
27. Rödel C, Grabenbauer GG, Papadopoulos T, et al. Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. J Clin Oncol 2003;21:3098-104.
28. Rödel C, Sauer R. Integration of novel agents into combined-modality treatment for rectal cancer patients. Strahlenther Onkol 2007;183:227-35.
29. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-40.
30. Sauer R, Fietkau R, Wittekind C, et al. Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO-94. Colorectal Dis 2003;5:406-15.
31. Semrau S, Gerber B, Reimer T, et al. Concurrent radiotherapy and taxane chemotherapy in patients with locoregional recurrence of breast cancer. Strahlenther Onkol 2006;182:596-603.
32. Shen W, Liu Y, Ma X, et al. Capecitabine combined with radiotherapy in Chinese patients with advanced or relapsed rectal carcinoma. Proc Am Soc Clin Oncol 2004;23:287.abstract 3671.
33. Twelves C, Wong A, Nowacki MP, et al. Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med 2005;352:2696-704.
34. Van Cutsem E, Findlay M, Osterwalder B, et al. Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: results of a randomized phase II study. J Clin Oncol 2000;18:1337-45.
35. Van Cutsem E, Hoff PM, Harper P, et al. Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomized, phase III trials. Br J Cancer 2004;90:1190-7.
36. Veerasarn V, Phromratanapongse P, Lorvidhava V, et al. Preoperative capacitabine with pelvic radiotherapy for locally advanced rectal cancer (phase I trial). J Med Assoc Thai 2006;89:1874-84.
37. Velenik V, Anderlih F, Oblak I, et al. Capecitabine as a radiosensitizing agent in neoadjuvant treatment of locally advanced respectable rectal cancer: prospective phase II trial. Croat Med J 2006;47:693-700.
38. Wong SJ, Sadasiwan C, Erickson B, et al. A phase I trial of preoperative capecitabine and concurrent radiation for locally advanced rectal cancer. Proc Am Soc Clin Oncol 2004;23:312.abstract 3771.
39. Yu CS, Kim TW, Kim JH, et al. Optimal time interval between capecitabine intake and radiotherapy in preoperative chemoradiation for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2007;67:1020-6.